Exposure to X-ray Radiation during Video Urodynamics for People with ANULTD secondary to SCI

Knight S1, Lee F1, Hamid R1

Research Type

Clinical

Abstract Category

Urodynamics

Abstract 212
Imaging
Scientific Podium Short Oral Session 13
Thursday 8th September 2022
17:30 - 17:37
Hall K1/2
Spinal Cord Injury Urodynamics Techniques Imaging
1. Royal National Orthopaedic Hospital
Online
Presenter
R

Rizwan Hamid

Links

Abstract

Hypothesis / aims of study
Following spinal cord injury (SCI), disruption to neuronal pathways to the bladder can lead to development of neurogenic lower urinary tract dysfunction (NLUTD). The goal of good bladder management is to ensure safe storage pressures and efficient voiding to protect the upper tracts. Videourodynamics (VCMG) is a functional test of the lower urinary tract in which pressure, capacity and flow data are simultaneously combined with real-time fluoroscopic imaging of the upper and lower urinary tract.  The NICE guidelines for management of NLUTD state that regular surveillance VCMGs should be performed in patients at high risk of upper tract damage. This may constitute a significant radiation exposure risk over a lifetime for which patients need to be consented. The guiding principle for all examinations requiring ionising radiation is ALARP – ‘as low as reasonably practicable’. The aim of this audit was to provide useful information for those requesting and performing VCMGs on exposure levels for people with SCI undergoing VCMG as part of their long-term bladder management.
Study design, materials and methods
Dose Area Product data for VCMG examinations between March 2021-March 2022 were extracted from the electronic database. Age, sex, level of injury and bladder management technique were recorded. During a standard VCMG investigation, single shots are taken of the bladder at infused volume (IV) of 30 ml and repeated if required during filling. Screening occurs during stress coughs at an IV of 75 ml and at end fill volume (EFV). Screening is also undertaken during the voiding phase if appropriate. Additional screening is undertaken if vesico-ureteric reflux is noted during the test.
Results
270 SCI patients were identified. The mean age was 50 years (range 12-87 years).  The mean, SD and range of DAP are shown in the table.
Interpretation of results
The greatest DAP were seen in the patients who voided due to the additional screening time during the voiding phase, compared to non-voiders. 16/270 patients had a DAP > 100 cGycm2. 14/16 of these were voiders. The remaining 2 patients had an IDUC, however, one of them had reflux so additional imaging of the kidneys and ureters was undertaken. Other factors affecting absorbed dose which were not analysed include body weight, height, fluoroscopic kV and fluoroscopy time. For comparison, the average DAP for an Abdominal AP x-ray is 260 cGycm2 and for an IVU 1400 cGycm2. The NDRL for Micturating Cystourethrogram is 700 cGycm2
Concluding message
Although VCMG is an important tool in the safe bladder management of people with NLUTD following SCI, the absorbed radiation dose should be considered when considering the frequency of the investigation.
Figure 1
Disclosures
Funding None Clinical Trial No Subjects Human Ethics not Req'd It was a Service Evaluation Helsinki not Req'd It was a Service Evaluation Informed Consent No
Citation

Continence 2S2 (2022) 100301
DOI: 10.1016/j.cont.2022.100301

03/02/2023 04:10:49